Lionel D. Lewis

Safety and Efficacy of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma: The CheckMate 016 Study

Hans J. Hammers, Elizabeth R. Plimack, Jeffrey R. Infante et al. · Journal of Clinical Oncology · 2017 · 502 citations · Full text

Tyrosine Kinase Inhibitor, Urology, Oncology +12

Phase I and Pharmacokinetic Study of YM155, a Small-Molecule Inhibitor of Survivin

Anthony W. Tolcher, Alain C. Mita, Lionel D. Lewis et al. · Journal of Clinical Oncology · 2008 · 239 citations · Full text

Phase I and Pharmacokinetic Study of Sorafenib in Patients With Hepatic or Renal Dysfunction: CALGB 60301

Antonius A. Miller, Daryl J. Murry, Kouros Owzar et al. · Journal of Clinical Oncology · 2009 · 207 citations · Full text

Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu.

Frank H. Valone, Peter A. Kaufman, Paul M. Guyre et al. · Journal of Clinical Oncology · 1995 · 183 citations

Immune Response in Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Intranodal Autologous Tumor Lysate-dendritic Cell Vaccination After Radiation Chemotherapy

Camilo E. Fadul, Jan L. Fisher, Thomas H. Hampton et al. · Journal of Immunotherapy · 2011 · 174 citations · Full text

Immunology, Immunoediting, Pathology +24